C. Ray Tallent

413 total citations
19 papers, 322 citations indexed

About

C. Ray Tallent is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, C. Ray Tallent has authored 19 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Organic Chemistry and 5 papers in Pharmacology. Recurrent topics in C. Ray Tallent's work include Analytical Chemistry and Chromatography (4 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Cannabis and Cannabinoid Research (3 papers). C. Ray Tallent is often cited by papers focused on Analytical Chemistry and Chromatography (4 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Cannabis and Cannabinoid Research (3 papers). C. Ray Tallent collaborates with scholars based in United States. C. Ray Tallent's co-authors include C. E. Cook, James H. Doroshow, John A. Kepler, H. Dix Christensen, Dennis E. Drayer, Monroe E. Wall, Herbert H. Seltzman, Rubin Bressler, George F. Taylor and David L. Williams and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Life Sciences and Phytochemistry.

In The Last Decade

C. Ray Tallent

19 papers receiving 296 citations

Peers

C. Ray Tallent

PHARM

SPECT

CCM

PHARM

Kenneth Y. Chan United States

Satoshi Ohmori Japan

B. Nieuweboer Germany

Jeffrey W. Cox United States

M Pays France

V. Tamassia Italy

Tillement Jp France

A Nomura Japan

Atsuhiro Mizuno Japan

Norbert Rietbrock Germany

Kenneth Y. Chan United States

C. Ray Tallent

88 ×1.2

78 ×1.2

PHARM

52 ×0.9

SPECT

40 ×1.0

CCM

47 ×1.1

PHARM

Citations per year, relative to C. Ray Tallent C. Ray Tallent (= 1×) peers Kenneth Y. Chan

Countries citing papers authored by C. Ray Tallent

Since Specialization

Citations

This map shows the geographic impact of C. Ray Tallent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Ray Tallent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Ray Tallent more than expected).

Fields of papers citing papers by C. Ray Tallent

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Ray Tallent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Ray Tallent. The network helps show where C. Ray Tallent may publish in the future.

Co-authorship network of co-authors of C. Ray Tallent

This figure shows the co-authorship network connecting the top 25 collaborators of C. Ray Tallent. A scholar is included among the top collaborators of C. Ray Tallent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Ray Tallent. C. Ray Tallent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Roche, M., et al.. (2012). Mild acetal cleavage using B-chlorocatecholborane in the synthesis of rearrangement-sensitive 2-arachidonoylglycerol. Tetrahedron Letters. 53(30). 3825–3827. 4 indexed citations

Tallent, C. Ray, et al.. (2007). AN IMPROVED PREPARATION OF 2, 2, 4, 4-TETRAMETHYL-6-AMINOTHIOCHROMAN, A KEY INTERMEDIATE TO UREA AND THIOUREA HETEROAROTINOIDS FOR ANTICANCER STUDIES. Organic Preparations and Procedures International. 39(1). 96–101. 5 indexed citations

Basta, Patricia V., et al.. (2004). Preparation of monoclonal antibodies reactive to the endogenous small molecule, anandamide. Journal of Immunological Methods. 285(2). 181–195. 6 indexed citations

Taylor, George F., et al.. (1993). Synthesis of [3″‐³H]taxol and [13‐³H]taxol¹. Journal of Labelled Compounds and Radiopharmaceuticals. 33(6). 501–515. 11 indexed citations

Tallent, C. Ray, et al.. (1987). Pharmacokinetics of pentobarbital enantiomers as determined by enantioselective radioimmunoassay after administration of racemate to humans and rabbits.. Journal of Pharmacology and Experimental Therapeutics. 241(3). 779–785. 25 indexed citations

Cook, C. E., et al.. (1986). Effect of introduction of 11-aminoaryl into 17α-cyanomethyl-17β-hydroxyestra-4,9-dien-3-one. Journal of Steroid Biochemistry. 25. 138–138. 3 indexed citations

Doroshow, James H., et al.. (1985). Ultrastructural features of Adriamycin-induced skeletal and cardiac muscle toxicity.. PubMed. 118(2). 288–97. 71 indexed citations

Cook, C. E., Dolores R. Brine, & C. Ray Tallent. (1984). Identification of in vitro rat metabolites of 1-phenylcyclohexene.. Drug Metabolism and Disposition. 12(2). 186–192. 2 indexed citations

Seltzman, Herbert H., et al.. (1982). Radioimmunoassays for Cannabinoids. PsycEXTRA Dataset. 42. 19–32. 13 indexed citations

10.

Tallent, C. Ray, et al.. (1982). Immunoassay of racemic drugs: a problem of enantioselective antisera and a solution.. Journal of Pharmacology and Experimental Therapeutics. 220(3). 568–573. 4 indexed citations

11.

Stephens, Robert J., et al.. (1982). Postnatal tolerance to NO2 toxicity. Experimental and Molecular Pathology. 37(1). 1–14. 10 indexed citations

12.

Cook, C. E., et al.. (1980). Radioimmunoassay for terfenadine in human plasma. Journal of Pharmaceutical Sciences. 69(12). 1419–1423. 24 indexed citations

13.

Cook, C. E., et al.. (1979). Warfarin enantiomer disposition: determination by stereoselective radioimmunoassay.. Journal of Pharmacology and Experimental Therapeutics. 210(3). 391–398. 20 indexed citations

14.

Cook, C. E., et al.. (1979). Synthesis of high specific activity R‐and S‐ warfarin‐³H. Journal of Labelled Compounds and Radiopharmaceuticals. 16(4). 623–631. 4 indexed citations

15.

Tallent, C. Ray, et al.. (1976). Caffeine in plasma and saliva by a radioimmunoassay procedure.. Journal of Pharmacology and Experimental Therapeutics. 199(3). 679–686. 65 indexed citations

16.

Cook, C. E., et al.. (1974). Antigens from synthetic and natural estrogens: Formation by conjugation with protein through a thiopropionic acid link. Life Sciences. 14(6). 1075–1087. 14 indexed citations

17.

Cook, C. E., et al.. (1972). NORETHYNODREL METABOLITES IN HUMAN PLASMA AND URINE. Journal of Pharmacology and Experimental Therapeutics. 183(1). 197–205. 19 indexed citations

18.

Cook, C. E. & C. Ray Tallent. (1969). Synthesis of (R)‐5‐(2′‐pentyl)barbituric acid derivatives of high optical purity. Journal of Heterocyclic Chemistry. 6(2). 203–206. 11 indexed citations

19.

Cook, C. E., et al.. (1969). An examination of the hexane extract of flue-cured tobacco involving gel permeation chromatography. Phytochemistry. 8(6). 1025–1033. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact